World Federation of Neurology

Fostering quality neurology and brain health worldwide

Home

About

Organisation

Trustees

Committees

Secretariat

WFN AGM and Elections

Code of Conduct

WFN Memorandum and Articles of Association

Contact Us

Global Networks

WFN Regional Neurological Associations

Global Neurology Alliance

WFN Specialty Groups

Organisation

Trustees

Global Networks

Global Neurology Alliance

Education

e-Learning Hub

Educational Videos

Training Centres

Neurological Department Visits

AAN-WFN Continuum Education Programme

CME Accreditation and Endorsement

WFN and WHO

e-Learning Hub

Training Centres

AAN-WFN Continuum Education Programme

WFN and WHO

Resources

Programmes

World Congress of Neurology

World Brain Day

Brain Health Inititaive

Neurological Needs Registry

WFN Grants and Awards

Covid-19 Resource Centre

Neuro-Covid Monthly Update

MonkeyPox and Neurology

News

WFN News

Press Releases

Neurology News

Neurology Events Calendar

WFN Meeting Endorsement

Programmes

Covid-19 Resource Centre

News

Neurology Events Calendar

Publications

World Neurology

Journal of the Neurological Sciences

eNeurologicalSci

WFN Featured articles

Journals of the WFN Regional Neurological Associations

World Neurology

Journal of the Neurological Sciences

eNeurologicalSci

WFN Featured articles

Membership

WFN Member Societies

Asian-Oceanian Region

European Region

Latin American Region

North American Region

Pan-African Region

Pan-Arab Region

Becoming a Member Society ⧉

Data Protection & Privacy ⧉

WFN Member Societies

Asian-Oceanian Region

Open search

Covid 19 notice 3

WFN COVID-19 reference review committee

Journal of the Neurological Sciences Editor-in-Chief: John D. England
eNeurologicalSci (eNS) standing Editor-in-Chief: Walter Struhal
World Neurology Editor-in-Chief: Steven L. Lewis

Quick links

Our work with the WHO
Monthly Update on Covid by the Tropical and Geographical Neurology Specialty Group
Journal of the Neurological Sciences
eNeurologicalSci
Covid-19 Resources

Dear WFN Member Societies,

When this COVID-19 website page was started at the beginning of the crisis in 2020, we intended to provide peer-reviewed information about the neurological consequences of COVID-19 as they came to light.

The pace of publications for Acute, Long, and Post- COVID-19, as well as Post Vaccination COVID-19, is fast and subject to many reviews. At present, we are overwhelmed with the Omicron variant as we continue the process of discovering the neurological sequelae of COVID-19.

At present, despite any estimations or predictions, we continue to be unable to foresee the end of the pandemic and must remain vigilant in regards to COVID-19's effects on neurological services and patients. We also have to be attentive to collateral effects, as many patients with neurological diseases or symptoms have less access to neurological services. In addition, regulations and bureaucracy at times bar older patients from even attempting access.

Additionally, neurological facilities are used to treat covid patients in some countries, which is acceptable given the circumstances, but we must be aware that the neurological workforce is thereby reduced.

These issues and problems are similar in all countries but differ in detail. As neurologists, we would encourage you to add your experiences and observations in the available databases, as these will assist in looking at the effects systematically and result in suggestions and new knowledge.

Prof. Wolfgang Grisold
President, World Federation of Neurology

WFN's work with WHO on Neurology and COVID 19: A Global Forum

As of January 2022, over 315 million confirmed cases of COVID-19 and over 5.5 million deaths had been reported to WHO https://covid19.who.int/.

Complications after acute viral illnesses are well described, and it has become clear that COVID-19 has several neurological manifestations. Epidemiological data also shows that people with pre-existing neurological conditions are more at risk of SARS COV 2 infection. In addition, interruptions to essential services, including access issues and supply chain interruptions for medications, are presenting further challenges for people with neurological conditions.

During the first wave of this pandemic, the WHO asked the WFN, as the organisation directly representing neurology and neurologists, to be represented on the WHO formed Neurology and COVID-19 Global Forum. The WFN continues to have involvement in this and also on its four working groups:

Follow-up and long-term impact
Essential Services
Acute clinical
Surveillance

Monthly Update on Covid by the Tropical and Geographical Neurology Specialty Group

COVID-19 July Update

Prof. Avindra Nath and Dr Bridgette Jeanne Billioux Tropical and Geographical Neurology Specialty Group

7 Jul 2022

In this month’s Neurology and COVID-19 review, we’ve included several topics that have arisen in the literature and news, including new updates regarding long COVID/PASC and neurologic outcomes of infants born to mothers with COVID-19.

Post-acute Sequelae of SARS-CoV-2 (PASC) or long COVID continues to be a puzzling entity; however, numerous new studies are underway to help better understand the nature of this syndrome and the mechanisms involved in its pathogenesis, including neurologic aspects. This month, the initial findings from the University of San Diego NeuCOVID longitudinal cohort study was published, describing the neurologic manifestations in two cohorts: patients referred to the Neurology department after recovering from COVID-19, and patients with pre-existing neurologic disorders who subsequently were diagnosed with COVID-19. In this cohort of 56 patients, fatigue was the most commonly reported symptom at baseline (89.3%), followed by headache (80.4%), insomnia (66.1%), and memory impairment (64.3%).

More...